Latest News about Johnson & Johnson
Recent news which mentions Johnson & Johnson
   How Trump's tariffs on Mexico and Canada will sweep across the U.S., state by state
   
  
  February 25, 2025
  From CNBC.com News
 
   Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
   
  
  January 21, 2025
  From CNBC.com News
 
   FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
   
  
  January 21, 2025
  From CNBC.com News
 
   Cramer's week ahead: Inauguration, earnings from Procter & Gamble and American Express
   
  
  January 17, 2025
  From CNBC.com News
 From CNBC.com News
 
   Zuckerberg says Biden administration pushed Meta 'super hard' to take down vaccine content
   
  
  January 10, 2025
  From CNBC.com News
 
   J&J says its lung cancer drug combination keeps people alive longer
   
  
  January 07, 2025
  From CNBC.com News
 
   Cramer's Lightning Round: Netflix is a buy
   
  
  December 11, 2024
  From CNBC.com News
 
   SpaceX valuation surges to $350 billion as company buys back stock
   
  
  December 11, 2024
  From CNBC.com News
 From CNBC.com News
 
   Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
   
  
  
  October 28, 2024
  From Benzinga
 
   Tuesday's big stock stories: What’s likely to move the market in the next trading session
   
  
  October 21, 2024
  From CNBC.com News
 
   Kenvue shares surge after activist Starboard takes stake
   
  
  October 21, 2024
  From CNBC.com News
 From CNBC.com News
 
   Cramer's week ahead: Major banks, Taiwan Semi and Netflix report as earnings season gets into full swing
   
  
  October 11, 2024
  From CNBC.com News
 
   Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
   
  
  
  September 05, 2024
  From Benzinga
 
   Cramer's Lightning Round: Dell is a buy
   
  
  August 26, 2024
  From CNBC.com News
 
   Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
   
  
  August 15, 2024
  From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
   
  
  August 06, 2024
  From CNBC.com News
 
   Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
   
  
  July 23, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  July 15, 2024
  From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
   
  
  June 07, 2024
  From CNBC.com News
 
   Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
   
  
  May 30, 2024
  From CNBC.com News
 From CNBC.com News
 
   Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
   
  
  May 01, 2024
  From CNBC.com News
 
   Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
   
  
  April 29, 2024
  From CNBC.com News
 From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  April 15, 2024
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
